Eli Lilly and Company (LLY)
SIX
Real-time Data
07:00 AM
Day's Range
1,010.0052 wk Range
565.00Overview - LLY - Eli Lilly and Company
Key Statistics
Valuation
Enterprise Value
756.07B
P/E (Trailing)
‪42.12‬
PEG Ratio
‪1.60‬
Price / Sales (TTM)
‪11.18‬
Price / Book
‪32.32‬
EV / EBITDA
‪22.68‬
Profitability
Gross Margin
‪85.77%‬
Profit Margin
‪33.52%‬
Operating Margin
‪54.22%‬
Return on Assets
‪20.35%‬
Return on Equity
‪102.28%‬
Ownership
Shares Outstanding
891.50M
Float
888.95M
Held by Insiders
‪0.15%‬
Held by Institutions
‪85.41%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪951.80‬
200-Day Avg
‪839.75‬
Dividends
Payout Ratio
‪21.69%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly and Company
Peers - LLY - Eli Lilly and Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- LLYSIXEli Lilly and Company900.27BMarket Cap+44.06%52-week change41.32P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson525.96BMarket Cap+20.88%52-week change30.19P/E (Trailing)‪21.48%‬Profit Margin
- ROSIXRoche Holding AG302.45BMarket Cap+28.35%52-week change24.75P/E (Trailing)‪19.60%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- NOVNEESIXNovartis AG248.37BMarket Cap+20.72%52-week change22.70P/E (Trailing)‪22.50%‬Profit Margin
- GILDSIXGilead Sciences Inc.145.04BMarket Cap+11.46%52-week change18.69P/E (Trailing)‪-10.63%‬Profit Margin
- PFESIXPfizer Inc.128.24BMarket Cap+8.04%52-week change36.29P/E (Trailing)‪6.80%‬Profit Margin
Profile Summary - LLY - Eli Lilly and Company
About
Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
